| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2023―Apr―24 |
Features of the pathogenesis of thyroid diseases in COVID-19 |
O.V. Maksim Maksim, B.V. Romashevsky Romashevsky, N.Yu. Demyanenko Demyanenko |
| 2 |
[GO] |
2023―Apr―21 |
Respiratory infections during the COVID-19 pandemic - what has changed? |
S.V. Nikolaeva Nikolaeva, E.K. Shushakova Shushakova |
| 3 |
[GO] |
2023―Feb―03 |
The prevalence and features of professional burnout among medical workers during the pandemic of a new coronavirus infection COVID-19 |
S.A. Babanov Babanov, N.E. Lavrentieva Lavrentieva, T.A. Azovskova Azovskova, N.A. Ostryakova Ostryakova |
| 4 |
[GO] |
2023―Feb―03 |
Exogenous glucocorticoids and the platelet component of the hemostasis system in COVID-19 |
N.V. Izmozherova Izmozherova, A.A. Popov Popov, I.P. Antropova Antropova, L.I. Kadnikov Kadnikov, Ya.V. Livshits Livshits, A.D. Kushtyeva Kushtyeva, et al. (+3) A.A. Nikonova Nikonova, V.M. Bakhtin Bakhtin, M.A. Shambatov Shambatov |
| 5 |
[GO] |
2023―Feb―03 |
Features of adaptation of medical students to the conditions of online education during the COVID-19 pandemic |
T.I. Bonkalo Bonkalo, S.V. Shmeleva Shmeleva, S.B. Kachalov Kachalov, M.V. Eremin Eremin, E.E. Ivashkova Ivashkova |
| 6 |
[GO] |
2023―Feb―03 |
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic |
A.E. Bagriy Bagriy, E.S. Mikhailichenko Mikhailichenko, A.V. Prikolota Prikolota, K.E. Mogilevskaya Mogilevskaya |
| 7 |
[GO] |
2023―Feb―03 |
Psoriasis, metabolic syndrome and COVID-19: a case report |
I.S. Vladimirova Vladimirova |
| 8 |
[GO] |
2023―Feb―03 |
Pediatric inflammatory multisystem syndrome associated with COVID-19: a clinical case |
O.A. Bashkina Bashkina, I.V. Vyazovaya Vyazovaya, D.F. Sergienko Sergienko |
| 9 |
[GO] |
2023―Feb―03 |
Preferences of Belgorod primary care phycisians in the treatment of a new coronavirus infection |
R.A. Bontsevich Bontsevich, Ya.R. Vovk Vovk, V.A. Vinyukov Vinyukov, D.G. Dubonosova Dubonosova |
| 10 |
[GO] |
2023―Feb―03 |
Features of the clinical course of a new coronavirus infection in children |
A.A. Turovskaya Turovskaya, E.M. Kostina Kostina, E.A. Orlova Orlova, E.Yu. Trushina Trushina, G.M. Grishanovich Grishanovich, O.G. Sidorova Sidorova, E.V. Avdoshina Avdoshina |
| 11 |
[GO] |
2023―Feb―03 |
Proadrenomedullin levels and clinical features of SARS-CoV-2 coronavirus infection: a prospective clinical study |
A.A. Astapovsky Astapovsky, V.N. Drozdov Drozdov, E.V. Shikh Shikh, N.B. Lazareva Lazareva, G.G. Melkonyan Melkonyan, A.A. Meshcheryakov Meshcheryakov, E.V. Tsepkova Tsepkova |
| 12 |
[GO] |
2023―Jan―31 |
A comorbid patient at a therapeutic reception during the COVID-19 pandemic. Current aspects of the rehabilitation period |
D.I. Trukhan Trukhan |
| 13 |
[GO] |
2022―May―16 |
Features of the management and follow-up of a “difficult” comorbid elderly patient with COVID-19 complications: a clinical case |
A.V. Tarantsova Tarantsova |
| 14 |
[GO] |
2022―Mar―02 |
Manifestation of primary adrenal insufficiency in a child against the background of a novel coronovirus infection COVID-19: a clinical case |
I.B. Zhurtova Zhurtova, M.A. Elgarova Elgarova, A.M. Gubachikova Gubachikova, M.R. Kurashinova Kurashinova |
| 15 |
[GO] |
2022―Feb―24 |
The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on the rehabilitation stage |
D.I. Trukhan Trukhan, E.L. Davydov Davydov |
| 16 |
[GO] |
2022―Feb―24 |
Antiarrhythmic therapy for atrial fibrillation in patients with the novel SARS-CoV-2 coronavirus infection: how to make the right choice? |
A.I. Tarzimanova Tarzimanova, E.E. Bykova Bykova |
| 17 |
[GO] |
2021―Dec―13 |
Possibility and prospects for the use of recombinant neutralizing monoclonal antibodies (bamlanivimab+etesevimab, sotrovimab) in patients with COVID-19 |
V.M. Tsvetov Tsvetov, I.S. Burashnikova Burashnikova, D.A. Sychev Sychev |
| 18 |
[GO] |
2021―Nov―09 |
Potentials for the use of glucocorticosteroids in inpatients with severe COVID-19 |
V.M. Tsvetov Tsvetov, A.V. Matveev Matveev, K.B. Mirzaev Mirzaev, V.A. Otdelnov Otdelnov, D.A. Sychev Sychev |
| 19 |
[GO] |
2021―Nov―09 |
Medical rehabilitation and sanatorium-resort treatment of patients with new coronavirus infection COVID-19 |
A.B. Achabaeva Achabaeva, D.A. Teuvazhukova Teuvazhukova, F.A. Kuchmezova Kuchmezova, I.A. Kalmykov Kalmykov, I.Kh. Gelyastanov Gelyastanov |
| 20 |
[GO] |
2021―Nov―09 |
The place and role of a therapist and general practitioner in the management of comorbid patients during the pandemic of the new coronavirus infection (COVID-19): an emphasis on non-specific prevention |
D.I. Trukhan Trukhan, E.L. Davydov Davydov |
| 21 |
[GO] |
2021―Aug―19 |
On the dermatological aspects of the novel coronavirus infection (COVID-19) |
I.V. Kosheleva Kosheleva, O.A. Bitkina Bitkina, L.I. Shadyzheva Shadyzheva, O.V. Andriyakhina Andriyakhina, A.Yu. Nikolaeva Nikolaeva, M.N. Fyrnina Fyrnina, et al. (+4) M.A. Deryavaya Deryavaya, K.S. Pershina Pershina, D.S. Zueva Zueva, A.A. Tsyganova Tsyganova |
| 22 |
[GO] |
2021―Aug―19 |
The rationale for the combined use of genetically engineered biological drugs in patients with COVID-19 |
I.S. Burashnikova Burashnikova |
| 23 |
[GO] |
2021―Aug―19 |
The rationale for re-administration of genetically engineered biological drugs in patients with COVID-19 |
I.S. Burashnikova Burashnikova |
| 24 |
[GO] |
2021―Jul―15 |
Skin lesions associated with new coronavirus infection (COVID-19) |
I.V. Kosheleva Kosheleva, O.A. Bitkina Bitkina, L.I. Shadyzheva Shadyzheva, A.Yu. Nikolaeva Nikolaeva, O.V. Andriyakhina Andriyakhina, O.A. Pankova Pankova, et al. (+2) E.S. Udalova Udalova, A.A. Tsyganova Tsyganova |
| 25 |
[GO] |
2021―Jun―21 |
Scientific rationale and prerequisites for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with COVID-19 |
V.A. Otdelenov Otdelenov, A.V. Matveev Matveev, K.B. Mirzaev Mirzaev, D.A. Sychev Sychev |
| 26 |
[GO] |
2021―Jun―21 |
Patients with bronchial asthma who have undergone COVID-19 |
E.Yu. Trushina Trushina, E.M. Kostina Kostina, E.A. Orlova Orlova |
| 27 |
[GO] |
2021―Jun―21 |
Clinical and pharmacological aspects of the use of drugs for COVID-19 in pregnant women |
V.M. Tsvetov Tsvetov, K.B. Mirzaev Mirzaev |
| 28 |
[GO] |
2021―Jun―21 |
New coronavirus infection COVID-19 in pregnant women: epidemiology, course, outcomes, prevention options |
T.E. Belokrinitskaya Belokrinitskaya, N.V. Artymuk Artymuk, O.S. Filippov Filippov, N.I. Frolova Frolova |
| 29 |
[GO] |
2021―Jun―21 |
The new COVID-19 virus and its impact on female sexual dysfunction |
M.N. Surina Surina, N.V. Artymuk Artymuk, A.V. Atalyan Atalyan, M. Al-Jefout Al-Jefout, O.O. Chernova Chernova |
| 30 |
[GO] |
2021―Jun―21 |
Experience of SLIT in patients with bronchial asthma through the prism of the coronavirus infection pandemic |
E.A. Orlova Orlova, E.M. Kostina Kostina, E.Yu. Trushina Trushina |
| 31 |
[GO] |
2021―Jun―21 |
The structure of the mRNA molecule in vaccines for the prevention of SARS-CoV-2 infection - not so simple |
A.V. Veselov Veselov |
| 32 |
[GO] |
2021―Apr―09 |
The role of metabolic drugs in the complex therapy of acute cerebrovascular accidents in patients with coronavirus infection COVID-19 |
E.B. Kuznetsova Kuznetsova, I.V. Sitkali Sitkali, O.V. Kolokolov Kolokolov, E.B. Likhacheva Likhacheva, A.M. Kolokolova Kolokolova, M.A. Polidanov Polidanov, A.R. Vasilieva Vasilieva |
| 33 |
[GO] |
2021―Apr―09 |
The role and place of telemedicine technologies in the rehabilitation of stroke patients in the context of the COVID-19 pandemic |
I.P. Parfenov Parfenov, R.V. Shirokiy Shirokiy, V.S. Fomin Fomin |
| 34 |
[GO] |
2021―Apr―05 |
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus |
M.Z. Ivanova Ivanova, I.B. Zhurtova Zhurtova, S.Kh. Sizhazheva Sizhazheva, A.M. Gubachikova Gubachikova |
| 35 |
[GO] |
2021―Apr―01 |
Scientific prerequisites and prospects for the use of sildenafil in patients with COVID-19 |
V.M. Tsvetov Tsvetov, A.V. Matveev Matveev |
| 36 |
[GO] |
2021―Apr―01 |
Possibility and prospects of using colchicine in patients with COVID-19, review update |
Yu.Yu. Kiselev Kiselev, A.V. Matveev Matveev |
| 37 |
[GO] |
2021―Mar―10 |
Evaluation of the scientific basis for the use of riamilovir for the treatment of COVID-19 |
K.B. Mirzaev Mirzaev, V.M. Tsvetov Tsvetov |
| 38 |
[GO] |
2021―Mar―10 |
Possibility and prospects of using bamlanivimab in patients with COVID-19 |
K.B. Mirzaev Mirzaev, D.A. Sychev Sychev |
| 39 |
[GO] |
2021―Mar―10 |
Typical changes in the lungs of children with covid-19, atypical treatment |
A.S. Polyakova Polyakova, M.D. Bakradze Bakradze, I.L. Mityushin Mityushin, I.L. Chashchina Chashchina, A.A. Tkacheva Tkacheva |
| 40 |
[GO] |
2021―Mar―10 |
The possibility and prospects of using cytostatics in patients with COVID-19 on the example of cyclophosphamide |
V.M. Tsvetov Tsvetov, I.S. Burashnikova Burashnikova, D.A. Sychev Sychev, I.V. Poddubnaya Poddubnaya |
| 41 |
[GO] |
2020―Dec―08 |
Possibilities of using glucocorticosteroids in the outpatient treatment of patients with COVID-19 |
Yu.Yu. Kiselev Kiselev, K.B. Mirzaev Mirzaev |
| 42 |
[GO] |
2020―Dec―08 |
Scientific rationale for the use of remdesivir in patients with COVID-19 |
K.B. Mirzaev Mirzaev, V.M. Tsvetov Tsvetov |
| 43 |
[GO] |
2020―Dec―08 |
Drug therapy for asymptomatic carriers of SARS-CoV-2 |
I.S. Burashnikova Burashnikova, V.M. Tsvetov Tsvetov |
| 44 |
[GO] |
2020―Nov―02 |
Analysis of the incidence of new coronavirus infection in oncological patients on the example of the oncological department of anticancer drug therapy of the Bashkir State Medical University |
N.O. Yuldasheva Yuldasheva, R.I. Kunafina Kunafina, D.D. Sakaeva Sakaeva, D.E. Baykov Baykov, R.R. Suleymanova Suleymanova |
| 45 |
[GO] |
2020―Sep―25 |
Treatment of a new coronavirus infection (COVID-19): opportunities and limitations |
O.V. Fesenko Fesenko, O.A. Sibiryakova Sibiryakova, S.N. Shvayko Shvayko |
| 46 |
[GO] |
2020―Sep―25 |
Therapeutic and diagnostic aspects of the new coronavirus infection COVID-19 in obstetric practice |
E.I. Kakhiani Kakhiani, N.A. Korobkov Korobkov, V.V. Vasiliev Vasiliev, E.S. Romanova Romanova |
| 47 |
[GO] |
2020―Sep―25 |
Algorithm of respiratory support for COVID-19 patients |
S.L. Babak Babak, M.V. Gorbunova Gorbunova, A.G. Malyavin Malyavin |
| 48 |
[GO] |
2020―Sep―25 |
Review of clinical guidelines for the treatment of children with confirmed coronavirus infection COVID-19: a clinical pharmacologist’s view |
S.B. Erofeeva Erofeeva, E.P. Smirnova Smirnova |
| 49 |
[GO] |
2020―Sep―25 |
COVID-19: selected clinical aspects through the prism of practical experience |
Yu.G. Belotserkovskaya Belotserkovskaya, S.S. Lebedev Lebedev, D.V. Vakatov Vakatov, I.A. Demina Demina, O. N. Sakara Sakara, A.G. Romanovskikh Romanovskikh, I.P. Smirnov Smirnov |
| 50 |
[GO] |
2020―Sep―25 |
Clinical experience of sublingual allergen-specific immunotherapy of allergic rhinitis in a coronavirus pandemic |
E.A. Orlova Orlova, E.M. Kostina Kostina, O.A. Kulikova Kulikova |
| 51 |
[GO] |
2020―Aug―03 |
Skin lesions associated with new coronavirus infection (COVID-19) |
I.V. Kosheleva Kosheleva, O.A. Bitkina Bitkina, L.I. Shadyzheva Shadyzheva, A.Yu. Nikolaeva Nikolaeva, O.V. Andriyakhina Andriyakhina, O.A. Pankova Pankova, et al. (+2) E.S. Udalova Udalova, A.A. Tsyganova Tsyganova |
| 52 |
[GO] |
2020―Jun―09 |
“PharmaCOVID” - information center for pharmacotherapy of patients with new coronavirus infection COVID-19 |
D.A. Sychev Sychev, K.B. Mirzaev Mirzaev, D.V. Ivashchenko Ivashchenko, Yu.Yu. Kiselev Kiselev, V.A. Otdelenov Otdelenov, A.V. Kryukov Kryukov, et al. (+4) V.M. Tsvetov Tsvetov, K.A. Zagorodnikova Zagorodnikova, A.V. Matveev Matveev, S.V. Glagolev Glagolev |
| 53 |
[GO] |
2020―Jun―09 |
COVID-19: lessons we are learning today (as of April 27, 2020) |
Yu.G. Belotserkovskaya Belotserkovskaya, A.I. Sinopalnikov Sinopalnikov |
